News & Media

Stay up to date with the latest press releases, media coverage, and company updates from Vyome Holdings.

Vyome Holdings Announces Positive Interim Data from Phase 2 Study of VT-1953 in Malignant Fungating Wounds (MFW)

Sep 4, 2025

Vyome Announces Strategic Review of Livechain (OTCID: LICH)

Aug 18, 2025

Vyome To Mark First Day of Trading as HIND with Nasdaq Opening Bell

Aug 15, 2025

Vyome Closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow

Aug 14, 2025

Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND

Aug 13, 2025

Vyome Announces New Board of Directors with Deep MIT and AI Ties

Aug 12, 2025

ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics

Aug 7, 2025

ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders

Jul 24, 2025

ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025

Jul 21, 2025

ReShape Lifesciences® Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys

Jun 26, 2025

Disclaimer

Disclaimer

*Certain statements on this site are forward-looking within the meaning of federal securities laws. Please see our full disclaimer here.

*Certain statements on this site are forward-looking within the meaning of federal securities laws. Please see our full disclaimer here.

A Cambridge, MA, based global healthcare platform synergizing biotech, medical devices, and AI.

Vyome Holdings, Inc.
Nasdaq: HIND

PRINCIPAL OFFICE

Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138

PHONE

+1 973-832-8147

SUBSIDIARIES

⁠Vyome Therapeutics, Inc.

OFFICE

Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138

Vyome Therapeutics Limited, Subsidiary of Vyome Therapeutics, Inc.

OFFICE

Plot No. 465, Ground Floor, F.I.E., Patparganj Industrial Area, Delhi, India- 110092.

PHONE

+91-99682-17333

*Certain statements on this site are forward-looking within the meaning of federal securities laws. Please see our full disclaimer here.

A Cambridge, MA, based global healthcare platform synergizing biotech, medical devices, and AI.

Vyome Holdings, Inc.
Nasdaq: HIND

PRINCIPAL OFFICE

Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138

PHONE

+1 973-832-8147

SUBSIDIARIES

⁠Vyome Therapeutics, Inc.

OFFICE

Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138

Vyome Therapeutics Limited, Subsidiary of Vyome Therapeutics, Inc.

OFFICE

Plot No. 465, Ground Floor, F.I.E., Patparganj Industrial Area, Delhi, India- 110092.

PHONE

+91-99682-17333

*Certain statements on this site are forward-looking within the meaning of federal securities laws. Please see our full disclaimer here.

Vyome Holdings, Inc.
Nasdaq: HIND

PRINCIPAL OFFICE

Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138

PHONE

+1 973-832-8147

SUBSIDIARIES

⁠Vyome Therapeutics, Inc.

OFFICE

Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138

Vyome Therapeutics Limited, Subsidiary of Vyome Therapeutics, Inc.

OFFICE

Plot No. 465, Ground Floor, F.I.E., Patparganj Industrial Area, Delhi, India- 110092.

PHONE

+91-99682-17333

*Certain statements on this site are forward-looking within the meaning of federal securities laws. Please see our full disclaimer here.